WELLS FARGO & COMPANY/MN - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 32 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$5,000
+400.0%
9,550
-20.7%
0.00%
Q4 2016$1,0000.0%12,050
+164.8%
0.00%
Q3 2016$1,0000.0%4,550
-23.5%
0.00%
Q2 2016$1,000
-50.0%
5,9500.0%0.00%
Q1 2016$2,000
-99.0%
5,950
-98.5%
0.00%
Q3 2015$205,000
-17.7%
394,950
-3.7%
0.00%
Q2 2015$249,000
-59.6%
410,150
-51.4%
0.00%
Q1 2015$616,000
+193.3%
844,600
+182.0%
0.00%
Q4 2014$210,000
+56.7%
299,500
+81.2%
0.00%
Q3 2014$134,000
+0.8%
165,250
+8.2%
0.00%
Q2 2014$133,000
-15.3%
152,750
+5.0%
0.00%
Q1 2014$157,000145,5000.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 20,000$57,0000.02%
View complete list of REXAHN PHARMACEUTICALS INC shareholders